Skip to main content
Journal cover image

Positron emission tomography: brain tumors and lung cancer.

Publication ,  Journal Article
Hagge, RJ; Wong, TZ; Coleman, RE
Published in: Radiol Clin North Am
September 2001

F-18 fluorodeoxyglucose positron emission tomography is a uniquely powerful diagnostic tool that noninvasively provides information that is critical to appropriate clinical management of patients with non-small cell lung cancer. Not only does the functional information provided by PET complement and clarify the anatomic information supplied by CT and MR imaging, but the superior sensitivity and negative predictive value of PET allow for improved accuracy in diagnosis, prognosis, staging, and monitoring the effects of treatment. With better information at their disposal, clinicians and patients are able to make better-informed decisions, contributing to more appropriate and more cost-effective medical care. Truly, FDG-PET has earned its place as the new standard of care in imaging non-small cell lung cancer.

Duke Scholars

Published In

Radiol Clin North Am

DOI

ISSN

0033-8389

Publication Date

September 2001

Volume

39

Issue

5

Start / End Page

871 / 881

Location

United States

Related Subject Headings

  • Tomography, Emission-Computed
  • Radiopharmaceuticals
  • Nuclear Medicine & Medical Imaging
  • Lung Neoplasms
  • Humans
  • Fluorodeoxyglucose F18
  • Brain Neoplasms
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hagge, R. J., Wong, T. Z., & Coleman, R. E. (2001). Positron emission tomography: brain tumors and lung cancer. Radiol Clin North Am, 39(5), 871–881. https://doi.org/10.1016/s0033-8389(05)70318-3
Hagge, R. J., T. Z. Wong, and R. E. Coleman. “Positron emission tomography: brain tumors and lung cancer.Radiol Clin North Am 39, no. 5 (September 2001): 871–81. https://doi.org/10.1016/s0033-8389(05)70318-3.
Hagge RJ, Wong TZ, Coleman RE. Positron emission tomography: brain tumors and lung cancer. Radiol Clin North Am. 2001 Sep;39(5):871–81.
Hagge, R. J., et al. “Positron emission tomography: brain tumors and lung cancer.Radiol Clin North Am, vol. 39, no. 5, Sept. 2001, pp. 871–81. Pubmed, doi:10.1016/s0033-8389(05)70318-3.
Hagge RJ, Wong TZ, Coleman RE. Positron emission tomography: brain tumors and lung cancer. Radiol Clin North Am. 2001 Sep;39(5):871–881.
Journal cover image

Published In

Radiol Clin North Am

DOI

ISSN

0033-8389

Publication Date

September 2001

Volume

39

Issue

5

Start / End Page

871 / 881

Location

United States

Related Subject Headings

  • Tomography, Emission-Computed
  • Radiopharmaceuticals
  • Nuclear Medicine & Medical Imaging
  • Lung Neoplasms
  • Humans
  • Fluorodeoxyglucose F18
  • Brain Neoplasms
  • 1103 Clinical Sciences